AbbVie Pre-Tax Income 2012-2026 | ABBV

AbbVie pre-tax income for the twelve months ending March 31, 2026 was $5.975B, a 64.96% increase year-over-year.

  • AbbVie annual pre-tax income for 2025 was $6.597B, a 77.53% increase from 2024.
  • AbbVie annual pre-tax income for 2024 was $3.716B, a 40.54% decline from 2023.
  • AbbVie annual pre-tax income for 2023 was $6.25B, a 53.62% decline from 2022.

AbbVie Pre-Tax Income 2012-2026 | ABBV

  • AbbVie annual pre-tax income for 2025 was $6.597B, a 77.53% increase from 2024.
  • AbbVie annual pre-tax income for 2024 was $3.716B, a 40.54% decline from 2023.
  • AbbVie annual pre-tax income for 2023 was $6.25B, a 53.62% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B